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Abstract
Non-pharmacological interventions may be beneficial in the management of rheumatoid arthritis related
fatigue. A narrative review was undertaken, with a focus upon research published in the past 6 years.
Seven studies were identified, four focusing upon physical activity, two on psychosocial interventions and
one that investigated aromatherapy and reflexology. Findings supported previous evidence that physical
activity and psychosocial interventions have potential to produce small to moderate reductions in fatigue
related to rheumatoid arthritis. Reflexology and aromatherapy interventions also appeared promising.
Limitations to the evidence included lack of consistency in fatigue measurement, and minimal data on
long-term outcomes and cost effectiveness. The wide range of physical activity interventions prevent
specific recommendations. For psychosocial interventions the strongest evidence is for group-based cog-
nitive behavioural approaches. There was lack of consideration given to fatigue mechanisms and inter-
vention design. Due to the complexity of fatigue, future research exploring personalized approaches is
warranted.
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Rheumatology key messages
. Fatigue related to rheumatoid arthritis may be improved through physical activity and psychological interventions.
. Cognitive behavioural therapy approaches have small to moderate effects on fatigue related to rheumatoid
arthritis.
. Research is needed to explore cost-effectiveness and personalized approaches to fatigue management in
rheumatoid arthritis.
Introduction
Fatigue is an important and common issue for people with
RA and was identified in research literature over 15 years
ago [1]. Despite this, a large number of patients still re-
ceive inadequate support. In a survey investigating the
impact of fatigue in RA, 51% of respondents (n= 2029)
never or rarely spoke to their general practitioner about
fatigue, and 47% never or rarely spoke to their rheuma-
tology healthcare professional. Further to this, the majority
of participants (79%) reported that their healthcare pro-
fessional never measured their level of fatigue [2]. The
subjective experience of fatigue can cause distress and
disruption to the daily lives of those with RA and influence
their everyday activities and approaches to living [35].
People with RA have described fatigue as ‘extreme and
persistent tiredness, weakness or exhaustion  mental,
physical or both’ [6]. Qualitative exploration of RA fatigue
has shown that it is often a frustrating and overwhelming
experience that can be frequent, unpredictable and unre-
solving, and often as severe, or more severe, than pain [3,
4]. To date, however, there is no consensus regarding a
definition of RA fatigue. The lack of an agreed definition
and the wide range of outcome measures used to deter-
mine the presence of RA fatigue have prevented accurate
reporting of prevalence, with rates of severe, clinically
relevant fatigue varying from 42% to over 80% [711].
RA fatigue appears to be a complex and multi-factorial
phenomenon and while a conceptual model has been pro-
posed [12], the precise mechanisms and causality remain
unclear [13]. Predictors of fatigue in RA are reported to
include inflammation (direct and indirect); cognitive be-
havioural elements (illness beliefs and stress, anxiety
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and depression, under- or overactivity); and personal fac-
tors (work, comorbidities, environment, support networks)
[14]. The evidence to support these predictors of RA fa-
tigue is, however, equivocal [13] with the presence of
comorbidities potentially exacerbating the fatigue experi-
ence [15] and further adding to its complexity.
Optimal pharmacological management of RA, with dis-
ease modifying anti-rheumatic drugs and biologic thera-
pies, appears to provide only small benefits for fatigue [16,
17]. These benefits may occur indirectly through reduction
of inflammation and/or pain [17]. Without amelioration of
the cognitive behavioural and personal factors contribut-
ing to RA fatigue, even optimal drug management is un-
likely to provide large benefit [16]. To address the
potentially complex and multifactorial nature of RA fa-
tigue, it is likely best managed as a symptom in its own
right using a multidimensional approach that incorporates
pharmacological and non-pharmacological approaches
[18].
Non-pharmacological interventions may alter the poten-
tial causal pathways of RA fatigue [12]. Psychosocial inter-
ventions, such as self-management programmes,
cognitive-behavioural approaches and lifestyle interven-
tions, or interventions based on physical activity have all
been proposed as potentially beneficial [12, 19]. A
Cochrane review published in 2013 [19] evaluated the
benefits and harm of non-pharmacological interventions
for the management of fatigue in people with RA.
Inclusion criteria for the review were relatively broad with
any randomized controlled trial included as long as it eval-
uated a non-pharmacological intervention in people with
RA where fatigue was included as an outcome. The main
stipulation was that fatigue had to be self-reported (sub-
jective) either as a primary or as a secondary outcome.
The majority of the 24 included studies investigated
physical activity interventions (n= 6) or psychosocial inter-
ventions (n= 13) with meta-analyses demonstrating stat-
istically significant small beneficial effects upon fatigue for
both intervention categories. Adverse events were not
well reported in the studies, preventing an accurate as-
sessment of potential for harm. In terms of quality, the
physical activity evidence was considered to be moderate
and the studies investigating psychosocial interventions
were considered low quality.
There were a number of limitations of the Cochrane
review. Firstly, due to the broad inclusion of fatigue as a
primary or secondary outcome the main purpose of the
interventions being investigated was rarely management
of fatigue. Interventions were therefore not designed spe-
cifically to reduce fatigue severity or impact with little or no
consideration given to underlying fatigue mechanisms.
Only one of the included studies identified fatigue as the
primary outcome; another reported fatigue impact as the
primary outcome; and a third study included tiredness as
one of three primary outcomes. Further to this, the pres-
ence of fatigue was not an inclusion criterion for 23/24 of
the studies, which is likely to have limited the potential for
improvement and resulted in smaller effect sizes. Limiting
the review inclusion criteria, however, would potentially
have resulted in an empty and uninformative review. A
further limitation of the review was the broad categoriza-
tion of interventions as physical activity or psychosocial,
preventing the identification of optimal parameters and
components.
The Cochrane review did, however, indicate that both
physical activity and psychosocial interventions have po-
tential for benefit in the management of fatigue in people
with RA [19]. Recommendations included the need to
design interventions specifically for fatigue management
in people with RA. High quality cost effectiveness trials of
these interventions with fatigue as the primary outcome
were also suggested. Linked to this, the need for a self-
reported measure of fatigue validated specifically for
people with RA was highlighted and since this time a new
outcome measure has been developed [20]. Further sys-
tematic reviews, published in 2015 and 2018, investigated
the effects of land-based aerobic training upon RA fatigue
and reported similar findings and limitations [21, 22].
Methods
It is now over 6 years since the literature search was car-
ried out to inform the Cochrane review and sufficient time
has passed to allow for the publication of a significant
body of new evidence. While similar reviews have been
undertaken since publication of the Cochrane review they
have had a much narrower focus [21, 22]. A narrative
review was therefore undertaken to identify key recent
research and explore whether the limitations in the evi-
dence base remain. The keyword search employed for
the Cochrane review was therefore repeated in February
2019, using the same electronic databases (see [19] for
details) and a historical cut-off date of October 2012.
Findings
The search revealed eight new studies investigating the
effect of a non-pharmacological intervention upon fatigue
in adults with RA. One of the eight studies was identified
as a feasibility study [22] with the full study subsequently
reported as a separate publication [23]. There were there-
fore only seven full trials considered for reporting, with
four of these broadly categorized as physical activity
[2326], two as psychosocial [27, 28], and the final study
investigating an aromatherapy intervention and a reflex-
ology intervention [29]. These seven studies are
summarized in Table 1.
It was promising to note that six of the studies identified
fatigue as the primary or joint primary outcome, indicating
a focus upon this symptom, with only one study including
fatigue as a secondary outcome [23]. It was also reassur-
ing that four of the seven studies screened out partici-
pants that were not experiencing significant fatigue [24,
27, 29], with a fifth study identifying ‘elevated distress’ as
an essential inclusion criterion [28]. In relation to the
measures used to assess fatigue, there remains a lack
of consistency across studies, with the Fatigue Severity
Scale [26, 29], visual analogue scale [23, 25], numerical
rating scale [27], patient-reported outcome measurement
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information system Fatigue Short Form [24], multidimen-
sional fatigue inventory [23] and Checklist Individual
Strength [28] all being used. Although fatigue was identi-
fied as a primary outcome for most studies, it was not
apparent that all the interventions had been designed spe-
cifically to target fatigue reduction.
In relation to the four studies that focused upon physical
activity interventions, three had identified fatigue as a pri-
mary or joint primary outcome. The home exercise plan
investigated by Durcan et al. [26] was individualized to
target functional limitations that were identified from par-
ticipant completion of the Health Assessment
Questionnaire. There was, however, no reference to fa-
tigue mechanisms in the design or implementation of the
intervention at an individual level. The pedometer inter-
vention, with or without step-targets, that was employed
by Katz et al. [24] aimed to increase participant physical
activity. The rationale provided for this approach was
based upon their previous research suggesting that phys-
ical inactivity was a primary independent predictor of
fatigue [30]. Feldthusen et al. [25] investigated a person-
centred physical therapy intervention that focused on
health-enhancing physical activity and balancing life activ-
ities. They suggested that this approach could strengthen
confidence and resources to control fatigue as well as
disease-related symptoms associated with fatigue.
Both psychosocial interventions that were investigated
identified fatigue as a primary or joint primary outcome.
The intervention described by Hewlett et al. [27] was ex-
plicitly linked to the management of RA fatigue with cog-
nitive behavioural therapy (CBT) approaches employed to
address ‘behaviours likely to be related to fatigue and
their underpinning thoughts and feelings’. In Ferwerda et
al. [28] participants completed at least one of four inter-
net-based intervention modules with fatigue being the
focus of one module. As a result, not all participants com-
pleted the fatigue module and despite fatigue being iden-
tified as a joint primary outcome, the overall purpose of
the intervention appeared to be reduction of distress. The
authors did, however, summarize the content of the fa-
tigue module, which included relevant cognitive and be-
havioural strategies.
The remaining study [29] investigated an aromatherapy
intervention and a reflexology intervention with fatigue as
a joint primary outcome. For aromatherapy, the oils were
identified including their active ingredients and proposed
physiological effects. While some of the proposed effects,
such as anti-inflammatory and anti-depressant properties,
might affect fatigue, this was not explicit from the infor-
mation provided. In relation to reflexology, the specific
points being stimulated were described, but how these
were of relevance to fatigue was not explained.
In relation to the effect of the interventions, three of the
four studies that investigated physical activity reported
significant improvement in fatigue at the end of the inter-
vention compared with a control arm [23, 25, 26]. Only one
study investigated longer-term outcomes with the differ-
ence between the physical activity arm, consisting of tai-
lored health enhancing physical activity and balancing life
activities, and the control arm, remaining significant at
6 months [25]. The final physical activity study reported a
reduction in fatigue over time in the pedometer and ped-
ometer plus step count arms, but this was not significantly
different from the control arm [24]. It should be noted,
however, that the target sample size was not reached,
which could potentially explain the lack of a significant
effect.
For the psychosocial interventions, Hewlett et al. [27]
reported a significant reduction in fatigue impact at
6 months in the ‘Reducing Arthritis Fatigue’ intervention
arm compared with the control arm. This difference re-
mained significant at the 2-year follow-up time point.
The intervention was delivered by trained nurses and oc-
cupational therapists and further to the findings from the
Cochrane review [19], supports the use of CBT
approaches for fatigue management in RA. In contrast,
Ferwerda et al. [28] identified a non-significant reduction
in fatigue over time for their internet-based cognitive be-
havioural intervention compared with the control arm. It
should, however, be noted that only 37/62 participants in
the intervention arm completed the internet-based fatigue
module. Further to this, although fatigue was identified as
one of several primary outcomes, the main purpose of the
intervention was to reduce distress levels and hence the
intervention did not solely focus upon fatigue.
Finally, Gok Metin and Ozdemir [29] identified signifi-
cant reduction in fatigue over time for both intervention
arms compared with the control arm with the reflexology
arm demonstrating greater reduction that the aromather-
apy arm. There were, however, some limitations to this
study including a lack of assessor blinding, the absence
of a long-term follow-up, and no active control arm.
Further research is therefore necessary before consider-
ation can be given to recommending aromatherapy or re-
flexology as an intervention for fatigue in adults with RA.
Discussion
The findings from these seven studies provide further evi-
dence that physical activity and psychosocial interven-
tions provide small to moderate benefit in relation to
self-reported fatigue in adults with RA. Further research
is still, however, needed to investigate the effectiveness of
psychosocial interventions other than those based upon
CBT. Reporting of adverse events remains limited, with
only one of the seven studies providing an explicit state-
ment [24]. Future research would also benefit from a more
consistent approach to assessment of fatigue. The Bristol
RA Fatigue (BRAF) Multidimensional Questionnaire may
be the most appropriate outcome as it was designed spe-
cifically to capture the multidimensional nature of RA-
related fatigue [31]. In addition to the multidimensional
questionnaire, there are three numerical rating scales
that measure fatigue coping, severity and effect. The
BRAF questionnaire and numerical rating scales are free
to access, available in 37 languages [20] and have been
shown to be valid, reliable and sensitive to change [32].
Implementation of the evidence in a clinical setting re-
quires careful consideration to ensure that interventions
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not only have the potential for benefit but are also accept-
able to people with RA and feasible to deliver in practice.
While the physical activity intervention delivered by
Durcan et al. [26] showed a beneficial effect on fatigue
post-intervention, there was no investigation of the long-
term effect. Given the intensive nature of the intervention,
it is likely that people with RA would struggle to adhere to
the prescribed home exercise plan in the long term. This
view is supported by findings from a systematic review
and meta-analysis of land-based aerobic training, which
demonstrated a small beneficial effect on RA fatigue at
12 weeks that did not remain significant at 24 weeks
[21]. The authors suggested that the lack of sustained
effect at 24 weeks was likely to be due to participants
discontinuation of the activity following a supervised pro-
gramme, most of which ended at 12 weeks. Adherence to
therapies, including physical activity, has been recognized
as a challenge in a wide range of long-term conditions
[33]. People with RA are, however, less physically active
than the general population with fatigue and physical limi-
tations are frequently identified as barriers [3437]. When
asked about fatigue management in a national RA survey
[2], 72% of respondents reported reducing activity levels
in response to fatigue, suggesting that physical activity
may be counter-intuitive for people already experiencing
fatigue. This suggests that interventions need to be de-
signed in collaboration with patients and effective meth-
ods to support long-term physical activity engagement
established, particularly for those experiencing RA-related
fatigue. It is possible that the intervention employed by
Thomsen et al. [23] to reduce daily sitting time through
motivational counselling and SMS reminders would be
more acceptable to people experiencing RA-related fa-
tigue than an intensive home exercise programme and
as a result more likely to be sustained long term. Further
research with long-term follow-up is, however, required to
explore these suggestions.
The majority of the psychosocial interventions identified
here and in the previous Cochrane review [19] were de-
livered by clinical psychologists. This creates barriers to
delivery in clinical practice due to the limited number of
rheumatology teams that include a clinical psychologist
[38]. It is, however, promising to note that the motivational
counselling in Thomsen et al. [23] to reduce sitting time
and the cognitive behavioural therapy approach in Hewlett
et al. [27] to support self-management of fatigue were de-
livered by rheumatology teams. For both of these studies
the health professionals (nurses and occupational therap-
ists) delivering the interventions received prior training
from a clinical psychologist. While delivery by health pro-
fessionals within rheumatology teams shows promise in
relation to fatigue outcomes, further research is necessary
to explore cost effectiveness. This is particularly important
given that the psychosocial interventions that have
demonstrated beneficial effects for fatigue have required
a time commitment from health professionals and pa-
tients. For example, the group intervention delivered by
Hewlett et al. [27] comprised seven sessions delivered
over 14 weeks (total of 13 h contact time); and Thomsen
et al. [23] provided three individual counselling sessions
with each one lasting up to 90 min (total 4 h 30 min), in
addition to SMS reminders.
The findings to date reinforce the Cochrane review con-
clusions [19] that physical activity and psychosocial inter-
ventions have the potential to produce small to moderate
benefit for RA-related fatigue. Several disease-specific
mechanisms have been proposed to explain these bene-
ficial effects. For example, high-intensity exercise has
been shown to restore muscle mass and function in RA
[39] with a result that less effort is required to carry out
physical tasks. Further to this, regular participation in mod-
erate to high-intensity exercise might improve self-effi-
cacy, well-being and a sense of self-control for people
with RA [40, 41]. Education programmes may help
people to change behaviours that perpetuate RA fatigue
or inhibit its self-management, such as through pacing and
lifestyle management, as well as by addressing mood and
coping strategies [12, 40]. Interventions that address
thoughts and feelings around fatigue may encourage help-
ful coping strategies, such as emotional expression, repri-
oritization and work and life balance, and help patients
reduce perceived stress and helplessness [19]. It is, how-
ever, possible that underpinning mechanisms of action are
not only disease-specific, with individual patient-specific
factors also being of importance. This suggestion is sup-
ported by findings of secondary analysis of data from a
range of cross-sectional studies, which indicated that the
type of chronic disease explained only 11% of the variance
in fatigue severity [42]. The explained variance increased to
55% when factors associated with fatigue were added
to the model (specifically, sex, age, motivational and con-
centration problems, pain, sleep disturbances, physical
functioning, reduced activity, and lower self-efficacy
concerning fatigue). This suggests that an individualized
approach to management that targets the relevant
fatigue-related factors may produce larger effects
than tightly controlled disease-specific interventions that
follow a set protocol. Due to the complexities of
manualizing such a personalized approach to manage-
ment, traditional randomized controlled trials may not be
possible or even desirable. In the future, alternative meth-
ods of investigation should therefore be considered, such
as realist evaluation in which the researcher seeks to iden-
tify ‘What works for whom, in what circumstances and
why?’ [43]. Through these methods, it may be possible
to identify the interventions that work best for people in
different contexts and with differing experiences of fatigue.
While limitations remain in relation to the evidence to
support the use of non-pharmacological interventions in
the management of RA-related fatigue, it is clear that they
have the potential to benefit. In relation to psychosocial
interventions, there is evidence that CBT approaches de-
livered by clinical psychologists or trained rheumatology
health professionals can reduce the short- and long-term
impact of RA fatigue. Future research investigating the
potential for individualized approaches to fatigue manage-
ment is warranted as well as investigation of a wider range
of psychosocial interventions.
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